Parnax Lab (506128)
FAST GROWERScore breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹94.8 |
| Market Cap | ₹108.88 Cr |
| P/E Ratio | 11.22 |
| ROCE | 13.97% |
| ROE | 6.02% |
| Dividend Yield | 0% |
| Profit Growth | 200.83% |
| Debt/Equity | — |
| Sales Growth | 56.49% |
| 52-Week Range | ₹96.25 — ₹182 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹19.8 |
Parnax Lab trades with a P/E ratio of 11.22, ROCE of 13.97%, ROE of 6.02%, profit growth of 200.83%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer